| Literature DB >> 20334965 |
Orit Raz1, Masoom A Haider, Sean R H Davidson, Uri Lindner, Eugen Hlasny, Robert Weersink, Mark R Gertner, Walter Kucharczyk, Walter Kucharcyzk, Stuart A McCluskey, John Trachtenberg.
Abstract
Two patients with low-risk prostate cancer (PCa) were treated with outpatient in-bore magnetic resonance imaging (MRI)-guided focal laser ablation. The tumor was identified on MRI. A laser fiber was delivered via a catheter inserted through a perineal template and guided to the target with MRI. The tissue temperature was monitored during laser ablation by MRI thermometry. Accumulated thermal damage was calculated in real time. Immediate post-treatment contrast-enhanced MRI confirmed devascularization of the target. No adverse events were noted. MRI-guided focal laser therapy of low-risk PCa is feasible and may offer a good balance between cancer control and side effects. Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20334965 DOI： 10.1016/j.eururo.2010.03.006
Source DB: PubMed Journal: Eur Urol ISSN： 0302-2838 Impact factor: 20.096